SineuGene Therapeutics is a biopharmaceutical company focusing on gene therapy for brain disorders. Founded in late 2021, the company builds on more than a decade of research on neuroscience by JiaLab at Tsinghua University's School of Medicine. With its expertise in gene expression and editing technology, and nucleic acid-mediated gene expression regulation, SineuGene is committed to developing effective treatments for neurological diseases such as ALS, stroke, Parkinson's disease, Alzheimer's disease, Huntington's chorea, Autism spectrum disorder.
Company Details
- Employees
- 1
- Founded
- -
- Address
- 1st Floor, Building 15th, Pkucare Innovation Park, Life Park Road, Changping District, Beijing,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.sineugene.com
- HQ
- Beijing
Sineugene Therapeutics Questions
Sineugene Therapeutics's website is http://www.sineugene.com
Sineugene Therapeutics's LinkedIn profile is https://cn.linkedin.com/company/sineugene-therapeutics
Sineugene Therapeutics has
1 employees.
View email and phone details for 1
employees at Sineugene Therapeutics.
Sineugene Therapeutics's industry is
Pharmaceutical Manufacturing
Sineugene Therapeutics's top competitors are
Poltreg S.a.,
Vaximm Ag,
Maat Pharma,
Secretome Therapeutics,
Tempero Bio,
Soleno Therapeutics, Inc.,
Coeptis, Inc,
Wave Life Sciences,
Yoda Therapeutics Inc.,
Antion Biosciences Sa.
Sineugene Therapeutics's categories are Pharmaceutical Manufacturing
Sineugene Therapeutics's founding year is 2021
